Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma

Biomarker-driven targeted therapies have been an area of exploration for innovative therapeutic options in oncology. B-cell lymphoma-2 (BCL-2) protein is an anti-apoptotic protein expressed on the clonal plasma cells in patients with multiple myeloma (MM). MM subsets with t (11;14) have overexpressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehsan, Hamid, Wahab, Ahsan, Shah, Zunairah, Sana, Muhammad Khawar, Masood, Adeel, Rafae, Abdul, Hashmi, Hamza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256917/
https://www.ncbi.nlm.nih.gov/pubmed/34267845
http://dx.doi.org/10.14740/jh844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256917/
https://www.ncbi.nlm.nih.gov/pubmed/34267845
http://dx.doi.org/10.14740/jh844

Ejemplares similares